Rockland Immunochemicals Expands Laboratories - - BioPharm International

ADVERTISEMENT

Rockland Immunochemicals Expands Laboratories


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 6

Rockland Immunochemicals is expanding its laboratories to address an increasing demand for life-science research tools, building a 60,000-ft2 facility in Limerick, PA. The new facilities will include cleanrooms for cell culture, suites for molecular biology, larger lot capacity production capabilities, and increased aseptic processing areas. Rockland began planning for its new facility in 2012.

Source: Rockland Immunochemicals

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here